The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K.-I., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedAdcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702613 · Cited by 119
RetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 3×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundThe language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 1×
“Besides acetylation, other posttranslational modifications such as phosphorylation and methylation also do occur in core histone tails (465, 466, 469, 470, 475).”
BackgroundNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 1×
“Many proinflammatory cytokines, aberrantly up-regulated in chronic inflammatory diseases, require the concerted activation of NF- B and AP-1, which are positively controlled by MAPK cascades (708, 709).”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Research works printed but not linked: 11
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI · Paper page
- Chen, 1999, Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells., J Cell Biochem, 74, 430, 10.1002/(sici)1097-4644(19990901)74:3<430::aid-jcb11>3.0.co;2-5 · DOI · Paper page
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Items 401–500 of 918
Fever in the Critically Ill: A Review of Epidemiology, Immunology, and Management
Niven, D. J., Léger, C., Stelfox, H. T., & Laupland, K. B. (2011) · Journal of Intensive Care Medicine · doi:10.1177/0885066611402463 · Cited by 41
“Glucocorticoids control the expression of pyrogenic cytokines by acting on the transcription factors nuclear factor-kB (NF-kB), activator protein-1 (AP-1), and their downstream products IL-1b, IL-6, and TNF-a.(30) In addition, fever is regulated by the production of several antipyretic cytokines, the most studied of w…”
BackgroundPerkins, M., Toit, R. L.-D., & Africander, D. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.07.022 · Cited by 46
Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1
Haffner, M. C., Jurgeit, A., Berlato, C., Geley, S., Parajuli, N., Yoshimura, A., & Doppler, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801041200 · Cited by 35
Taniguchi, Y., Iwasaki, Y., Tsugita, M., Nishiyama, M., Taguchi, T., Okazaki, M., Nakayama, S., Kambayashi, M., Hashimoto, K., & Terada, Y. (2010) · Endocrinology · doi:10.1210/en.2009-1254 · Cited by 36
Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?
Михайловна, Ж. Е., Lylova, E. S., Grigoreva, D. D., Игоревич, К. К., Osipova, A. V., Kulikov, E. P., Александрович, М. С., Belitsky, G. A., Budunova, I. V., Геннадиевна, Я. М., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179686 · Cited by 36
Airway Smooth Muscle–Specific Transcriptomic Signatures of Glucocorticoid Exposure
Kan, M., Koziol‐White, C. J., Shumyatcher, M., Johnson, M. T., Jester, W. F., Panettieri, R. A., & Himes, B. E. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0385oc · Cited by 37
ISG12 is a critical modulator of innate immune responses in murine models of sepsis
Uhrín, P., Perkmann, T., Binder, B. R., & Schabbauer, G. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.009 · Cited by 36
Sung, C., Chen, L., Limbutara, K., Jung, H. J., Gilmer, G. G., Yang, C., Lin, S., Khositseth, S., Chou, C., & Knepper, M. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.015 · Cited by 36
Bei, E., Salpeas, V., Pappa, D., Anagnostara, C., Alevizos, V., & Moutsatsou, P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.002 · Cited by 35
“…GC—GR complex may prevent other transcription factors, via protein—protein interactions, such as activator protein-1 (AP1) and nuclear factor kB (NF-kB), from activating their target genes being known as transrepression effect (Blanco et al., 1998; McKenna et al., 1999; De Bosscher et al., 2003).”
Mukhopadhyay, N. K., Ferdinand, A. S., Mukhopadhyay, L., Cinar, B., Lutchman, M., Richie, J. P., Freeman, M. R., & Liu, B. C. ‐. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.07.017 · Cited by 35
Cho, I. J., & Kim, S. G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0257 · Cited by 37
Roles of alternative splicing in modulating transcriptional regulation
Li, J., Wang, Y., Rao, X., Wang, Y., Feng, W., Liang, H., & Liu, Y. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0465-6 · Cited by 37
“There are two major mechanisms of gene regulation by GR [17, 18], direct positive regulation via glucocorticoid-response elements (GRE), and indirect regulation that is mediated via crosstalk with other TF proteins, including MDM2 and TP53 [19–21].”
BackgroundStanilova, S. A., Dobreva, Z. G., Slavov, E., & Miteva, L. D. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.12.003 · Cited by 35
Chiloeches, A., Sánchez‐Pacheco, A., Gil-Araujo, B., Aranda, A., & Lasa, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0107 · Cited by 38
“Moreover, glucocorticoids can inhibit NF- B in a variety of ways in different cell contexts, including inhibition of DNA binding, I B kinase (IKK) activity, and p65/NF- B transactivation (58).”
BackgroundKondo, Y., Fukuda, K., Adachi, T., & Nishida, T. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1897 · Cited by 34
Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression
Zheng, Y., Ishiguro, H., Ide, H., Inoue, S., Kashiwagi, E., Kawahara, T., Jalalizadeh, M., Reis, L. O., & Miyamoto, H. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1128 · Cited by 34
Li, C., Huang, B., & Zhang, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14010065 · Cited by 35
Northcott, M., Gearing, L. J., Nim, H. T., Nataraja, C., Hertzog, P. J., Jones, S. A., & Morand, E. F. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00006-0 · Cited by 36
Dejager, L., Pinheiro, I., Puimège, L., Fan, Y.-D., Gremeaux, L., Vankelecom, H. E. J., & Libert, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154484 · Cited by 35
Sevilla, L. M., Bayo, P., Latorre, V., Sanchís, A., & Pérez, P. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0183 · Cited by 42
Lasa, M., Gil-Araujo, B., Palafox, M., & Aranda, A. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0298 · Cited by 34
Sohn, K., Jang, S., Choi, D.-K., Lee, Y., Yoon, T., Jeon, E. K., Kim, K. H., Seo, Y., Lee, J., Park, J.-K., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.065 · Cited by 34
Verstrepen, L., Adib‐Conquy, M., Kreike, M., Carpentier, I., Adrie, C., Cavaillon, J., & Beyaert, R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00187.x · Cited by 36
Understanding stress through the genome
Meijer, O. C. (2006) · Stress · doi:10.1080/10253890600799669 · Cited by 34
“The other mode of gene regulation by glucocorticoids is via binding of the receptors to other transcription factors, and interfering with their transcription regulation (De Bosscher et al. 2003).”
BackgroundIntracellular Molecular Signaling: Basis for Specificity to Glucocorticoid Anti‐inflammatory Actions
Liberman, A. C., Druker, J., Aprile-Garcia, F., Holsboer, F., & ARZT, E. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03958.x · Cited by 39
Lesovaya, E. A., Yemelyanov, A. Y., Игоревич, К. К., Попа, А. В., Belitsky, G. A., Геннадиевна, Я. М., Gordon, L. I., Rosen, S. T., & Budunova, I. V. (2012) · Cell Cycle · doi:10.4161/cc.23048 · Cited by 35
“It is well-accepted that GR transrepression is mostly mediated via negative interaction between GR and other transcription factors, including NFkB and AP-1.”
BackgroundInfluentialXiang, G., Fan, M., Ma, Y., Wang, M., Gao, J., Chen, J., Li, X., Xue, W., Wang, Y., Gao, H., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.003 · Cited by 34
Glycine suppresses TNF-alpha-induced activation of NF-κB in differentiated 3T3-L1 adipocytes
Blancas‐Flores, G., Alarcón-Aguilar, F. J., García-Macedo, R., Almanza-Pérez, J. C., Flores-Saenz, J. L., Román‐Ramos, R., Ventura-Gallegos, J. L., Kumate, J., Zentella‐Dehesa, A., & Cruz, M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.06.025 · Cited by 33
Bladh, L.-G., Johansson-Haque, K., Rafter, I., Nilsson, S. V., & Okret, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.013 · Cited by 32
“This protein-protein interaction between GR and NF-κB on the DNA (tethering) is a key step in the cross-talk mechanism by which GCs repress NF-κB activity [2,4].”
BackgroundLi, Q., Chen, L., Yan, M., Shi, X., & Zhong, M. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.993038 · Cited by 33
Inhibition of the NF-κB Signaling Pathway by a Novel Heterocyclic Curcumin Analogue
Katsori, A., Palagani, A., Bougarne, N., Hadjipavlou‐Litina, D., Haegeman, G., & Berghe, W. V. (2015) · Molecules · doi:10.3390/molecules20010863 · Cited by 34
“Dexamethasone (DEX) and withaferin A (WA) were included as reference immunosuppressive compounds [19,66].”
BackgroundSelf-citationdos Santos, N. B., Novaes, L. S., Dragunas, G., Rodrigues, J. R., Brandão, W. N., Camarini, R., Peron, J. P. S., & Munhoz, C. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-43217-3 · Cited by 35
Safety and Efficacy of Fluticasone Propionate in the Topical Treatment of Skin Diseases
Roeder, A., Schaller, M., Schäfer‐Korting, M., & Korting, H. C. (2004) · Skin Pharmacology and Physiology · doi:10.1159/000081680 · Cited by 32
Predicting specificity-determining residues in two large eukaryotic transcription factor families
Donald, J. E., & Shakhnovich, E. I. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki755 · Cited by 34
“While not a part of nuclear receptor DNA binding, this pathway is of great importance to the cell ( 40 ).”
BackgroundGola, H., Engler, A., Morath, J., Adenauer, H., Elbert, T., Kolassa, I.-T., & Engler, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086333 · Cited by 30
“Upon hormone binding, the activated GR translocates to the nucleus and acts as a ligand-dependent transcription factor that modulates the expression of GCresponsive genes or modifies the activity of other transcription factors such as NF-kB or AP-1 [6,7].”
BackgroundGiembycz, M. A., & Newton, R. C. (2015) · F1000Prime Reports · doi:10.12703/p7-16 · Cited by 31
Casonato, A., Daidone, V., Sartorello, F., Albiger, N. M. E., Romualdi, C., Mantero, F., Pagnan, A., & Scaroni, C. M. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06907.x · Cited by 32
“How this comes about may involve several mechanisms; glucocorticoids affect responsive cells, e.g. endothelial cells, by activating a cytoplasmatic glucocorticoid receptor to directly or indirectly regulate target gene transcription (Karin, 1998; De Bosscher et al, 2003; Hayashi et al, 2004).”
BackgroundGu, X., Peng, L., Yang, D. L., Ma, Q., Zheng, Y., Liu, C., Zhu, B., Song, L., Sun, X., & Ma, Z. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.012 · Cited by 32
“Many experiments have confirmed that deactivation of the NF-κB could attenuate allodynia and hyperalgesia (Ledeboer et al., 2005; Meunier et al., 2007).”
BackgroundInfluentialA nuclear factor kappa B-derived inhibitor tripeptide inhibits UVB-induced photoaging process
Oh, J. E., Kim, M. S., Jeon, W.-K., Seo, Y., Kim, B.-C., Hahn, J. H., & Park, C. S. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.10.002 · Cited by 32
George, C. L., Birnie, M. T., Flynn, B. P., Kershaw, Y. M., Lightman, S. L., & Conway-Campbell, B. L. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.019 · Cited by 34
Şencan, S., Edipoğlu, İ. S., Demir, F. G. Ü., Yolcu, G., & Gündüz, O. H. (2019) · The Korean journal of pain · doi:10.3344/kjp.2019.32.4.301 · Cited by 31
“ing enzymes related with pro-inflammatory cytokines, chemokines, and inflammation [15,17,18].”
BackgroundSarusi-Portuguez, A., Grbeša, I., Tal, M., Deitch, R., Raz, D., Kliker, L., Weismann, R., Schwartz, M., Loza, O., Cohen, L., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac488 · Cited by 32
“Another mechanism suggested for transcriptional repression by GR involves competition with other transcription factors for a limited amount of co-activators (9).”
BackgroundCorticosteroid Intravitreal Implants
de Smet, M. D. (2012) · Developments in ophthalmology · doi:10.1159/000336330 · Cited by 30
Fakhri, S., Abbaszadeh, F., & Jorjani, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111563 · Cited by 30
Wilson, C., Scullin, P., Worthington, J., Seaton, A., Maxwell, P., O’Rourke, D. M., Johnston, P. G., McKeown, S. R., Wilson, R., O’Sullivan, J. M., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604804 · Cited by 30
“…have been shown to interfere with the transcriptional activity of nuclear factor-kB (NF-kB) and activator protein-1 (AP-1) (Nishimura et al, 2001), resulting in the suppression of the interleukin-6 (IL-6) and the NF-kB–IL-6 pathways in CaP (Akakura et al, 2003; De Bosscher et al, 2003).”
BackgroundLim, D., Kim, J. H., & Kim, Y. T. (2016) · Nutrients · doi:10.3390/nu8120760 · Cited by 31
GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression
Chinenov, Y. V., Sacta, M. A., Cruz, A. R., & Rogatsky, I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810863105 · Cited by 30
Roach, B. L., Kelmendi‐Doko, A., Balutis, E. C., Marra, K. G., Ateshian, G. A., & Hung, C. T. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0018 · Cited by 32
“Once internalized, dex acts directly and indirectly by activating anti-inflammatory proteins,(74,75) upregulating their production through glucocorticoidresponsive elements located on DNA,(76,77) and by interfering with the translocation of other transcriptional factors, such as nuclear factor-kappa B.(78,79) As a cul…”
BackgroundSasse, S. K., Altonsy, M. O., Kadiyala, V., Cao, G., Panettieri, R. A., & Gerber, A. N. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00179.2016 · Cited by 30
Café-Mendes, C. C., Garay-Malpartida, M., Malta, M. B., Lima, L. D. S., Scavone, C., Ferreira, Z. S., Markus, R. P., & Marcourakis, T. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.056 · Cited by 31
Hidasi, A. O., Groh, K. J., Suter, M. J. ‐., & Schirmer, K. (2016) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2016.11.024 · Cited by 33
Local glucocorticoid production in the thymus
Talabér, G., Jondal, M., & Okret, S. (2015) · Steroids · doi:10.1016/j.steroids.2015.06.010 · Cited by 30
“[66,67].”
Bischoff, D. S., Zhu, J. H., Makhijani, N. S., Kumar, A., & Yamaguchi, D. T. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21450 · Cited by 31
“This pathway is sensitive to inhibition by glucocorticoids [McKay and Cidlowski, 1999; Bosscher et al., 2003].”
BackgroundArgenziano, M., Dianzani, C., Ferrara, B., Swaminathan, S., Manfredi, A., Ranucci, E., Cavalli, R., & Ferruti, P. (2017) · Gels · doi:10.3390/gels3020022 · Cited by 28
Crisafulli, U., Xavier, A. M., dos Santos, F. B., Cambiaghi, T. D., Chang, S. Y., Porcionatto, M. A., Castilho, B. A., Malnic, B., & Glezer, I. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00050 · Cited by 28
“GCs have been successfully used for several decades for treating inflammatory diseases (Tsurufuji et al., 1979; Scheinman et al., 1995; Almawi et al., 1996; De Bosscher et al., 2003; Xavier et al., 2016).”
BackgroundThe role of O-GlcNAcylation in innate immunity and inflammation
Wang, Y., Fang, X., Wang, S., Wang, B., Chu, F., Tian, Z., Zhang, L., & Zhou, F. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac065 · Cited by 30
“…receptor ( GR ) can interact with and inhibit the functions of NF- κB family members, thereby repressing the transcription of numerous pro-inflammatory genes downstream of NF- κB, such as interleukin-8 ( IL-8 ) and intracellular adhesion molecule-1 ( ICAM-1 ) ( De Bosscher et al., 2003 ) .”
Parveen, N., Masood, A., Iftikhar, N., Minhas, B. F., Minhas, R., Nawaz, U., & Abbasi, A. A. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-122 · Cited by 28
“Typically, specific type of cooperativity (similar set of distinct TFs) is required to regulate diverse set of genes exhibiting temporally and spatially synchronized expression (co-expressed genes) [25,26].”
BackgroundHapgood, J. P., & Tomasicchio, M. (2010) · Archives of Virology · doi:10.1007/s00705-010-0678-0 · Cited by 32
“However, in addition to the mutual antagonism of GR and NFjB/AP-1, several other mechanisms are involved in transrepression, and these mechanisms are likely to vary depending on the target promoter as well as cell type [21–23].”
BackgroundInfluentialSperlich, J., Kerr, R. G., & Teusch, N. E. (2017) · Marine Drugs · doi:10.3390/md15090262 · Cited by 32
Mendoza-Milla, C., Rodríguez, C. M., Alarcón, E. C., Estrada‐Bernal, A., Toledo‐Cuevas, E. M., Martínez‐Martínez, E., & Zentella‐Dehesa, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.081 · Cited by 28
Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes
Migita, K., Koga, T., Torigoshi, T., Maeda, Y., Miyashita, T., Izumi, Y., Aiba, Y., Komori, A., Nakamura, M., Motokawa, S., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/kep089 · Cited by 30
Beck, I. M. E., Berghe, W. V., Gerlo, S., Bougarne, N., Vermeulen, L., Bosscher, K. D., & Haegeman, G. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.008 · Cited by 29
“complex and translocates into the nucleus, where it can act to modulate transactivation of mostly glucocorticoid response element (GRE)-containing promoters or transrepression of targeted genes mostly via crosstalk with kinases, cofactors or transcription factors such as NF-kB [21,22].”
BackgroundSelf-citationBischoff, D. S., Zhu, J., Makhijani, N. S., & Yamaguchi, D. T. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21714 · Cited by 29
“This pathway is sensitive to inhibition by glucocorticoids [McKay and Cidlowski, 1999; Bosscher et al., 2003], and we have previously shown that the IL-1b/TNF-a-stimulated CXCL8 expression is partially suppressed by DEX in hMSCs [Bischoff et al., 2007].”
BackgroundOnda, K., Nagashima, M., Kawakubo, Y., Inoue, S., Hirano, T., & Oka, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.032 · Cited by 28
Lin, K., Sun, S.-P., Wu, J.-I., & Wang, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178937 · Cited by 28
Role of Endogenous Glucocorticoids in Cancer in the Elderly
Ayroldi, E., Cannarile, L., Adorisio, S., Delfino, D. V., & Riccardi, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123774 · Cited by 29
“Most GC effects are genomic and mediated by glucocorticoid receptor (GR), a transcription factor that regulates gene expression either by binding to GC response elements in the promoters of the target genes or by interacting with other transcription factors, such as activator protein-1 (AP-1) or NF-κB, inhibiting thei…”
BackgroundFever suppression in near-term pregnant rats is dissociated from LPS-activated signaling pathways
Mouihate, A., Ellis, S., Harré, E.-M., & Pittman, Q. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00342.2005 · Cited by 29
Drebert, Z. J., Bracke, M., & Beck, I. M. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.02.002 · Cited by 32
“This indirect modulation of transcription, often occurring in transrepression, solidly contributes to the anti-inflammatory properties of GCs [10–12].”
BackgroundInfluentialLai, J., Hui-Chun, W., & Qin, A. (2021) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2020.0213 · Cited by 34
Transcriptional control of parturition: insights from gene regulation studies in the myometrium
Khader, N., Shchuka, V. M., Shynlova, O. P., & Mitchell, J. A. (2021) · Molecular Human Reproduction · doi:10.1093/molehr/gaab024 · Cited by 26
Sibila, O., Restrepo, M. I., & Anzueto, A. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.11.014 · Cited by 27
Tone, A. A., Virtanen, C., Shaw, P. H., & Brown, T. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0199 · Cited by 31
“shown to inhibit AP-1 signaling (15); this transcriptional complex activates a subset of inflammatory genes and is a target of transrepression by glucocorticoid receptor (39).”
BackgroundDexamethasone Inhibits the Pro-Angiogenic Potential of Primary Human Myoblasts
Langendorf, E. K., Rommens, P. M., Drees, P., & Ritz, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157986 · Cited by 25
“GCs play a key role in the suppression of inflammation by inhibiting the transcription of the cytokines through binding to the GR and the activated GR interacts with several transcription factors in a positive or negative manner [39].”
BackgroundJoshi, T., Johnson, M. W., Newton, R. C., & Giembycz, M. A. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13087 · Cited by 25
“British Journal of Pharmacology (2015) 172 2634–2653 2635 interactions with the agonist-bound glucocorticoid receptor (NR3C1; here on referred to as GR) (De Bosscher et al., 2003).”
BackgroundNuclear receptors: mediators and modifiers of inflammation-induced cholestasis
Mulder, J., Karpen, S. J., Tietge, U. J., & Kuipers, F. (2009) · Frontiers in bioscience · doi:10.2741/3400 · Cited by 26
“1 GR GR has been studied extensively for its antiinflammatory properties (199).”
BackgroundVisser, K., Smith, C., & Louw, A. (2010) · Endocrinology · doi:10.1210/en.2010-0368 · Cited by 28
Lei, Y., Cao, Y.-X., Xu, C., & Zhang, Y. (2008) · Respiratory Research · doi:10.1186/1465-9921-9-71 · Cited by 25
“This agrees well with other reports that glucocorticoids reduce airway hyperreactivity in asthmatic airways [36,37] and diminish airway inflammation [38-40].”
ResultRole of innate inflammation in traumatic brain injury
Bourgeois-Tardif, S., Beaumont, L. D., Rivera, J. C., Chemtob, S., & Weil, A. G. (2021) · Neurological Sciences · doi:10.1007/s10072-020-05002-3 · Cited by 29
“Abbreviations AP-1, activator protein 1; ATP, adenosine triphosphate; BBB, blood-brain barrier; BDNF, brain-derived neurotrophic factor; CNS, central nervous system; CSF, cerebrospinal fluid; CSF1R, colony stimulating factor 1 receptor; DAI, diffuse axonal injury; DAMPs, danger-associated molecular patterns; EPO, eryt…”
BackgroundZhang, Y., Adner, M., & Cardell, L. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02207.x · Cited by 25
“Glucocorticoids reduce airway hyperreactivity in the asthmatic airways [36-39] and diminish airway inflammation via inhibition of the transcription factors AP-1 and NF-kB activities [28, 29, 33-35].”
BackgroundChebotaev, D. V., Yemelyanov, A. Y., Lavker, R. M., & Budunova, I. V. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700992 · Cited by 27
Chebotaev, D. V., Yemelyanov, A. Y., Zhu, L., Lavker, R. M., & Budunova, I. V. (2006) · Oncogene · doi:10.1038/sj.onc.1210108 · Cited by 26
“There are two major mechanisms of gene regulation by GR (Beato et al., 1995; De Bosscher et al., 2003; Necela and Cidlowski, 2004).”
BackgroundMurakami, Y., Ito, S., Atsumi, T., & Fujisawa, S. (2005) · PubMed · Cited by 25
Modulation of nuclear receptor function by cellular redox poise
Carter, E. L., & Ragsdale, S. W. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.01.005 · Cited by 27
Morgan, X. C., Ni, S., Miranker, D. P., & Iyer, V. R. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-445 · Cited by 24
“Numerous transcription factors are known to cooperate in certain contexts; for example, it is known that many genes involved in inflammation are regulated by Ap-1 and NFκB [30].”
BackgroundDezitter, X., Fagart, J., Taront, S., Fay, M., Masselot, B., Hétuin, D., Formstecher, P., Rafestin-Oblin, M. E., & Idziorek, T. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.085860 · Cited by 27
Kawate, H., Wu, Y., Ohnaka, K., & Takayanagi, R. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.11.020 · Cited by 24
Bacterial lipopolysaccharide induces type 2 deiodinase in cultured rat astrocytes
Lamirand, A., Ramauge, M., Pierre, M., & Courtin, F. (2011) · Journal of Endocrinology · doi:10.1677/joe-10-0218 · Cited by 24
“Repression of NF-kB activity by glucocorticoids has indeed been reported to depend on promoter and cell type (De Bosscher et al. 2003).”
BackgroundSimko, V., Takáčová, M., Debreova, M., Laposova, K., Ondriskova, E., Pastoreková, S., Csáderová, L., & Pastorek, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3621 · Cited by 26
“However, regulation mediated by GRs can lead also to the transrepression depending on a promoter context and GRE sequence present (56).”
BackgroundDesmet, S. J., Bougarne, N., Moortel, L. V., Cauwer, L. D., Thommis, J., Vuylsteke, M., Ratman, D., Houtman, R., Tavernier, J. H., & Bosscher, K. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-07941-y · Cited by 25
PI3K signaling promotes formation of lipid-laden foamy macrophages at the spinal cord injury site
Ryan, C. B., Choi, J. S., Kang, B., Herr, S., Pereira, C., Moraes, C. T., Al-Ali, H., & Lee, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106370 · Cited by 23
“Another mechanism by which PI3Ks regulate the NF κ B inflammatory pathway includes the glucocorticoid pathway, with ligand-bound glucocorticoid receptors interfering with NF κ B transcription of pro-inflammatory gene programs (De Bosscher et al., 2003; Ozes et al., 1999).”
BackgroundHan, Y.-M., Kim, M. S., Jo, J., Shin, D., Kwon, S., Seo, J. B., Kang, D., Lee, B. D., Ryu, H., Hwang, E. M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01016-1 · Cited by 23
Haridas, V., Xu, Z., Kitchen, D. B., Jiang, A., Michels, P. C., & Gutterman, J. U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028037 · Cited by 27
“Most of the undesirable side effects of GCs such as central adiposity, dyslipidaemia, skeletal muscle wasting, osteoporosis, insulin resistance, glucose tolerance and diabetes have been attributed to the transactivation arm of GR”
BackgroundFamilial Mediterranean fever: the molecular pathways from stress exposure to attacks
Korkmaz, C., Cansu, D. Ü., & Cansu, G. B. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa450 · Cited by 24
Iwaki, H., Sasaki, S., Matsushita, A., Ohba, K., Matsunaga, H., Misawa, H., Oki, Y., Ishizuka, K., Nakamura, H., & Suda, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088610 · Cited by 25
Amanda, M., Dave, F., Pados, G., Tsolakidis, D., Gidron, Y., Pang, Y., Thomas, P., Hall, M., & Karteris, E. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3410 · Cited by 25
“Cortisol exerts its actions by binding to and activating glucocorticoid receptors (11,12).”
The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation
PSARRA, A. M. G., SOLAKIDI, S., & SEKERIS, C. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.019 · Cited by 22
IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling
Manjur, A. B. M. K., Lempiäinen, J. K., Malinen, M., Palvimo, J. J., & Niskanen, E. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105382 · Cited by 25
de Jong, P. H. P., Quax, R. A. M., Huisman, M., Gerards, A., Feelders, R. A., de Sonnaville, P. B., Luime, J. J., Weel, A. E. A. M., & Hazes, J. M. W. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202152 · Cited by 22
The risk and outcomes of pneumonia in patients on inhaled corticosteroids
Sibila, O., Soto-Gomez, N., & Restrepo, M. I. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.04.001 · Cited by 25
Bougarne, N., Mylka, V., Ratman, D., Beck, I. M. E., Thommis, J., Cauwer, L. D., Tavernier, J. H., Staels, B., Libert, C., & Bosscher, K. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01769 · Cited by 23
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.